Thomas Flaten
Stock Analyst at Lake Street
(3.28)
# 1,078
Out of 5,122 analysts
34
Total ratings
41.67%
Success rate
7.18%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $27.12 | +84.37% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.71 | +232.10% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.51 | +156.41% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $4.78 | +130.13% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $50.02 | +39.94% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.61 | +70.83% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $2.75 | +190.91% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $8.05 | +73.91% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.55 | +213.73% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $6.80 | +488.24% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $39.34 | -11.03% | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $6.38 | +25.39% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $7.97 | +12.92% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $9.15 | +391.80% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.70 | +134.04% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $24.66 | +1.38% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.93 | +155,558.85% | 2 | Nov 17, 2022 |
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $27.12
Upside: +84.37%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.71
Upside: +232.10%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.51
Upside: +156.41%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $4.78
Upside: +130.13%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $50.02
Upside: +39.94%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.61
Upside: +70.83%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $2.75
Upside: +190.91%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $8.05
Upside: +73.91%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.55
Upside: +213.73%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $6.80
Upside: +488.24%
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $39.34
Upside: -11.03%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $6.38
Upside: +25.39%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $7.97
Upside: +12.92%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $9.15
Upside: +391.80%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.70
Upside: +134.04%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.66
Upside: +1.38%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.93
Upside: +155,558.85%